Nonalcoholic Fatty Liver Disease: Current Issues and Novel Treatment Approaches
Romina Lomonaco, Nishanth E. Sunny, Fernando Bril et al. · Drugs · 2013
Cited by 158 works. doi:10.1007/s40265-012-0004-0
Authors
References
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆
- MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial
- Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
- Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
- The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
- Long‐term follow‐up of patients with NAFLD and elevated liver enzymes†‡
- Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
- Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association